M&A Deal Summary

Foundation Consumer Healthcare Acquires Plan B One-Step

On September 18, 2017, Foundation Consumer Healthcare acquired life science company Plan B One-Step from Teva Pharmaceutical Industries for 675M USD

Acquisition Highlights
  • This is Foundation Consumer Healthcare’s 1st transaction in the Life Science sector.
  • This is Foundation Consumer Healthcare’s largest (disclosed) transaction.
  • This is Foundation Consumer Healthcare’s 1st transaction in Israel.

M&A Deal Summary
Date 2017-09-18
Target Plan B One-Step
Sector Life Science
Buyer(s) Foundation Consumer Healthcare
Sellers(s) Teva Pharmaceutical Industries
Deal Type Divestiture
Deal Value 675M USD

Target

Plan B One-Step

Petach Tikva, Israel
Plan B One-Step comprises of value brands of emergency contraception, Take Action, Aftera, and Next Choice One Dose.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Foundation Consumer Healthcare

Pittsburgh, Pennsylvania, United States
Category Company
Founded 2014
Sector Medical Products
DESCRIPTION

Foundation Consumer Healthcare is dedicated to improving consumers’ lives by developing and growing a portfolio of differentiated over-the-counter (OTC) products. Foundation Consumer Healthcare was founded in 2014 and is based in Pittsburgh, Pennsylvania.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 2
Country (Israel) 1 of 1
Year (2017) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-07-16 GSK Consumer Healthcare - seven brands

Brentford, United Kingdom

GSK Consumer Healthcare's seven brands portfolio of products includes Breathe Right Nasal Strips and Children’s Dimetapp, pharmacist-recommended brand for children's cough and cold products, as well as Anbesol, Alavert, Dristan, Primatene Tablets and FiberCon. The addition of these brands will expand Foundation’s marketing presence to an additional 32 markets globally.

Buy -

Seller(S) 1

SELLER

Teva Pharmaceutical Industries

Tel Aviv, Israel
Category Company
Founded 1901
Sector Life Science
Employees35,001
Revenue 15.8B USD (2023)
DESCRIPTION

Teva Pharmaceutical Industries is a provider of pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Teva Pharmaceutical Industries was founded in 1901 and is based in Tel Aviv, Israel.

DEAL STATS #
Overall 6 of 9
Sector (Life Science) 5 of 8
Type (Divestiture) 6 of 8
Country (Israel) 4 of 4
Year (2017) 2 of 2
Size (of disclosed) 3 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-09-11 Teva Pharmaceutical Industries - PARAGARD

Buffalo, New York, United States

PARAGARD is a copper-releasing device that is placed in the uterus to prevent pregnancy for up to 10 years.

Sell $1.1B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-02-01 Thermamex

London, United Kingdom

Theramex is a global specialty pharmaceutical company dedicated to women and their health. The Company markets a broad range of branded and branded generic products across 50 countries around the world. The portfolio, which is dedicated to women's health, focuses on contraception, fertility, menopause and osteoporosis and includes key brands such as Ovaleap®, Zoely®, Seasonique®, Actonel®, Estreva® and Lutenyl®. Thermamex is based in London, United Kingdom.

Sell $703M
Mergr

Product

Company

Legal